ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity

Clinical trial NCT00263965 · TERMINATED

Trial details

NCT number: NCT00263965
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2005-08-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.